Structure

Physi-Chem Properties

Molecular Weight:  464.27
Volume:  488.761
LogP:  4.715
LogD:  3.973
LogS:  -4.42
# Rotatable Bonds:  6
TPSA:  63.52
# H-Bond Aceptor:  6
# H-Bond Donor:  1
# Rings:  5
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.665
Synthetic Accessibility Score:  3.889
Fsp3:  0.536
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.553
MDCK Permeability:  1.751709532982204e-05
Pgp-inhibitor:  0.992
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.94
30% Bioavailability (F30%):  0.568

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.822
Plasma Protein Binding (PPB):  88.76229095458984%
Volume Distribution (VD):  1.693
Pgp-substrate:  4.863559722900391%

ADMET: Metabolism

CYP1A2-inhibitor:  0.091
CYP1A2-substrate:  0.947
CYP2C19-inhibitor:  0.061
CYP2C19-substrate:  0.929
CYP2C9-inhibitor:  0.035
CYP2C9-substrate:  0.435
CYP2D6-inhibitor:  0.737
CYP2D6-substrate:  0.932
CYP3A4-inhibitor:  0.111
CYP3A4-substrate:  0.928

ADMET: Excretion

Clearance (CL):  10.815
Half-life (T1/2):  0.587

ADMET: Toxicity

hERG Blockers:  0.939
Human Hepatotoxicity (H-HT):  0.254
Drug-inuced Liver Injury (DILI):  0.905
AMES Toxicity:  0.029
Rat Oral Acute Toxicity:  0.409
Maximum Recommended Daily Dose:  0.971
Skin Sensitization:  0.82
Carcinogencity:  0.032
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.837

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC66573

Natural Product ID:  NPC66573
Common Name*:   Psychotrine
IUPAC Name:   n.a.
Synonyms:   Psychotrine
Standard InCHIKey:  NCALAYAMQHIWMN-REIDKSKDSA-N
Standard InCHI:  InChI=1S/C28H36N2O4/c1-5-17-16-30-9-7-19-13-27(33-3)28(34-4)15-22(19)24(30)11-20(17)10-23-21-14-26(32-2)25(31)12-18(21)6-8-29-23/h12-15,17,20,24,31H,5-11,16H2,1-4H3/t17-,20-,24-/m0/s1
SMILES:  CC[C@H]1CN2CCc3c([C@@H]2C[C@@H]1CC1=NCCc2c1cc(OC)c(c2)O)cc(c(c3)OC)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL463445
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0002659] Emetine alkaloids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28941 Pogonopus speciosus Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[10514334]
NPO28941 Pogonopus speciosus Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[1982768]
NPO28941 Pogonopus speciosus Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 > 10.0 ug ml-1 PMID[485179]
NPT83 Cell Line MCF7 Homo sapiens ED50 > 10.0 ug ml-1 PMID[485179]
NPT139 Cell Line HT-29 Homo sapiens ED50 > 10.0 ug ml-1 PMID[485179]
NPT459 Individual Protein Human immunodeficiency virus type 1 reverse transcriptase Human immunodeficiency virus 1 IC50 > 200.0 ug.mL-1 PMID[485180]
NPT459 Individual Protein Human immunodeficiency virus type 1 reverse transcriptase Human immunodeficiency virus 1 Inhibition = 20.0 % PMID[485180]
NPT1034 Cell Line Lu1 Homo sapiens ED50 = 5.7 ug ml-1 PMID[485181]
NPT1851 Cell Line Col2 Homo sapiens ED50 = 4.5 ug ml-1 PMID[485181]
NPT91 Cell Line KB Homo sapiens ED50 = 2.8 ug ml-1 PMID[485181]
NPT91 Cell Line KB Homo sapiens ED50 = 9.0 ug ml-1 PMID[485181]
NPT91 Cell Line KB Homo sapiens ED50 = 9.4 ug ml-1 PMID[485181]
NPT858 Cell Line LNCaP Homo sapiens ED50 = 2.3 ug ml-1 PMID[485181]
NPT2345 Cell Line SW626 Homo sapiens ED50 = 13.3 ug ml-1 PMID[485181]
NPT136 Cell Line SK-N-SH Homo sapiens ED50 = 4.0 ug ml-1 PMID[485181]
NPT726 Cell Line M109 Mus musculus ED50 = 9.0 ug ml-1 PMID[485181]
NPT140 Organism Artemia Artemia LC50 > 1000.0 ppm PMID[485179]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 1.0 ug ml-1 PMID[485179]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. ED50 = 3.4 ug ml-1 PMID[485181]
NPT992 Organism Entamoeba histolytica Entamoeba histolytica IC50 = 8.19 ug.mL-1 PMID[485182]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC66573 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9548 High Similarity NPC216816
0.9097 High Similarity NPC192768
0.9097 High Similarity NPC220858
0.9097 High Similarity NPC97221
0.9097 High Similarity NPC88249
0.9097 High Similarity NPC151895
0.8951 High Similarity NPC121275
0.8951 High Similarity NPC4138
0.8951 High Similarity NPC284183
0.8917 High Similarity NPC476568
0.8868 High Similarity NPC39701
0.8868 High Similarity NPC54379
0.8868 High Similarity NPC249797
0.8868 High Similarity NPC127674
0.8868 High Similarity NPC278799
0.8868 High Similarity NPC110416
0.8868 High Similarity NPC207757
0.8868 High Similarity NPC5238
0.8868 High Similarity NPC184026
0.8868 High Similarity NPC204828
0.8868 High Similarity NPC469817
0.8868 High Similarity NPC276588
0.8868 High Similarity NPC172765
0.8868 High Similarity NPC189266
0.8868 High Similarity NPC295691
0.8868 High Similarity NPC193949
0.8868 High Similarity NPC2413
0.8846 High Similarity NPC24233
0.8846 High Similarity NPC476571
0.8846 High Similarity NPC147390
0.8846 High Similarity NPC246587
0.8846 High Similarity NPC135538
0.8846 High Similarity NPC428
0.8782 High Similarity NPC321505
0.8782 High Similarity NPC191376
0.8782 High Similarity NPC179825
0.878 High Similarity NPC256012
0.878 High Similarity NPC42549
0.878 High Similarity NPC240841
0.878 High Similarity NPC317272
0.878 High Similarity NPC268503
0.878 High Similarity NPC250846
0.8735 High Similarity NPC109925
0.8704 High Similarity NPC111485
0.8686 High Similarity NPC85381
0.8678 High Similarity NPC41122
0.8678 High Similarity NPC318805
0.8654 High Similarity NPC185838
0.8645 High Similarity NPC476567
0.8645 High Similarity NPC136860
0.8645 High Similarity NPC128019
0.8553 High Similarity NPC103379
0.8553 High Similarity NPC477565
0.8519 High Similarity NPC187022
0.8519 High Similarity NPC80129
0.8509 High Similarity NPC37272
0.8494 Intermediate Similarity NPC276944
0.8494 Intermediate Similarity NPC238530
0.8494 Intermediate Similarity NPC24465
0.8494 Intermediate Similarity NPC232514
0.8491 Intermediate Similarity NPC7467
0.8483 Intermediate Similarity NPC234318
0.8462 Intermediate Similarity NPC475215
0.8462 Intermediate Similarity NPC108434
0.8447 Intermediate Similarity NPC76213
0.8447 Intermediate Similarity NPC277669
0.8443 Intermediate Similarity NPC264850
0.8443 Intermediate Similarity NPC13916
0.8428 Intermediate Similarity NPC476144
0.8428 Intermediate Similarity NPC106295
0.8428 Intermediate Similarity NPC210437
0.8428 Intermediate Similarity NPC16107
0.8428 Intermediate Similarity NPC51957
0.8428 Intermediate Similarity NPC476151
0.8397 Intermediate Similarity NPC213206
0.8397 Intermediate Similarity NPC328750
0.8397 Intermediate Similarity NPC188163
0.8397 Intermediate Similarity NPC474915
0.8354 Intermediate Similarity NPC247639
0.8354 Intermediate Similarity NPC25084
0.8343 Intermediate Similarity NPC249996
0.8333 Intermediate Similarity NPC314682
0.8333 Intermediate Similarity NPC476202
0.8323 Intermediate Similarity NPC324144
0.8323 Intermediate Similarity NPC207824
0.8323 Intermediate Similarity NPC60538
0.8313 Intermediate Similarity NPC27410
0.8313 Intermediate Similarity NPC166014
0.8276 Intermediate Similarity NPC195538
0.8276 Intermediate Similarity NPC286119
0.8274 Intermediate Similarity NPC253043
0.8274 Intermediate Similarity NPC196447
0.8274 Intermediate Similarity NPC306843
0.8274 Intermediate Similarity NPC96603
0.8274 Intermediate Similarity NPC212794
0.8274 Intermediate Similarity NPC477563
0.8274 Intermediate Similarity NPC78222
0.8274 Intermediate Similarity NPC136508
0.8274 Intermediate Similarity NPC13504
0.8258 Intermediate Similarity NPC131204
0.8258 Intermediate Similarity NPC301050
0.8242 Intermediate Similarity NPC186063
0.8232 Intermediate Similarity NPC477564
0.8232 Intermediate Similarity NPC2295
0.8229 Intermediate Similarity NPC42663
0.8229 Intermediate Similarity NPC271013
0.8229 Intermediate Similarity NPC258657
0.8229 Intermediate Similarity NPC217748
0.8229 Intermediate Similarity NPC49075
0.8229 Intermediate Similarity NPC279228
0.8229 Intermediate Similarity NPC8836
0.8229 Intermediate Similarity NPC90998
0.8229 Intermediate Similarity NPC7715
0.8229 Intermediate Similarity NPC328155
0.8229 Intermediate Similarity NPC15414
0.8229 Intermediate Similarity NPC251735
0.8229 Intermediate Similarity NPC182052
0.8229 Intermediate Similarity NPC229373
0.8229 Intermediate Similarity NPC239824
0.8229 Intermediate Similarity NPC290582
0.8229 Intermediate Similarity NPC104196
0.8229 Intermediate Similarity NPC185639
0.8229 Intermediate Similarity NPC290005
0.8229 Intermediate Similarity NPC181796
0.8229 Intermediate Similarity NPC223690
0.8229 Intermediate Similarity NPC54654
0.8229 Intermediate Similarity NPC285931
0.8229 Intermediate Similarity NPC222661
0.8229 Intermediate Similarity NPC311973
0.8229 Intermediate Similarity NPC30779
0.8204 Intermediate Similarity NPC205167
0.8182 Intermediate Similarity NPC167116
0.8182 Intermediate Similarity NPC274716
0.8182 Intermediate Similarity NPC254441
0.8176 Intermediate Similarity NPC12053
0.8176 Intermediate Similarity NPC117188
0.8176 Intermediate Similarity NPC205421
0.8176 Intermediate Similarity NPC306555
0.8176 Intermediate Similarity NPC145832
0.8176 Intermediate Similarity NPC81218
0.8176 Intermediate Similarity NPC158376
0.8176 Intermediate Similarity NPC474931
0.8171 Intermediate Similarity NPC233029
0.8171 Intermediate Similarity NPC133011
0.8171 Intermediate Similarity NPC82285
0.8171 Intermediate Similarity NPC210148
0.8133 Intermediate Similarity NPC146288
0.8133 Intermediate Similarity NPC147091
0.8125 Intermediate Similarity NPC294249
0.8107 Intermediate Similarity NPC475393
0.8098 Intermediate Similarity NPC92541
0.8095 Intermediate Similarity NPC249274
0.809 Intermediate Similarity NPC212237
0.809 Intermediate Similarity NPC116465
0.8072 Intermediate Similarity NPC41178
0.8072 Intermediate Similarity NPC138487
0.8072 Intermediate Similarity NPC216459
0.807 Intermediate Similarity NPC210140
0.8047 Intermediate Similarity NPC60186
0.8045 Intermediate Similarity NPC275680
0.8045 Intermediate Similarity NPC22115
0.8037 Intermediate Similarity NPC475959
0.8035 Intermediate Similarity NPC239775
0.8023 Intermediate Similarity NPC83198
0.8023 Intermediate Similarity NPC204908
0.8013 Intermediate Similarity NPC218530
0.8012 Intermediate Similarity NPC81247
0.8012 Intermediate Similarity NPC35627
0.8012 Intermediate Similarity NPC476573
0.8011 Intermediate Similarity NPC32154
0.8 Intermediate Similarity NPC274661
0.8 Intermediate Similarity NPC48490
0.8 Intermediate Similarity NPC206900
0.8 Intermediate Similarity NPC175890
0.8 Intermediate Similarity NPC1229
0.8 Intermediate Similarity NPC82457
0.8 Intermediate Similarity NPC11296
0.7977 Intermediate Similarity NPC69712
0.7977 Intermediate Similarity NPC477562
0.7977 Intermediate Similarity NPC26240
0.7975 Intermediate Similarity NPC144863
0.7963 Intermediate Similarity NPC5462
0.7956 Intermediate Similarity NPC191132
0.7956 Intermediate Similarity NPC60295
0.7953 Intermediate Similarity NPC134858
0.7953 Intermediate Similarity NPC169743
0.7952 Intermediate Similarity NPC275027
0.7952 Intermediate Similarity NPC18614
0.7952 Intermediate Similarity NPC26601
0.7949 Intermediate Similarity NPC6854
0.7949 Intermediate Similarity NPC285078
0.7949 Intermediate Similarity NPC313737
0.7943 Intermediate Similarity NPC199465
0.7943 Intermediate Similarity NPC229166
0.7943 Intermediate Similarity NPC128560
0.7939 Intermediate Similarity NPC274026
0.7933 Intermediate Similarity NPC302245
0.7933 Intermediate Similarity NPC95426
0.7933 Intermediate Similarity NPC16357
0.7917 Intermediate Similarity NPC31311

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC66573 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8519 High Similarity NPD7298 Approved
0.8512 High Similarity NPD5602 Clinical (unspecified phase)
0.8434 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.8428 Intermediate Similarity NPD4584 Approved
0.8397 Intermediate Similarity NPD4664 Clinical (unspecified phase)
0.8232 Intermediate Similarity NPD4773 Phase 2
0.8232 Intermediate Similarity NPD4772 Phase 2
0.8229 Intermediate Similarity NPD8054 Approved
0.8229 Intermediate Similarity NPD8053 Approved
0.8118 Intermediate Similarity NPD4010 Discontinued
0.7988 Intermediate Similarity NPD3639 Approved
0.7988 Intermediate Similarity NPD3641 Approved
0.7988 Intermediate Similarity NPD3640 Phase 3
0.795 Intermediate Similarity NPD6658 Clinical (unspecified phase)
0.7892 Intermediate Similarity NPD4005 Discontinued
0.7889 Intermediate Similarity NPD7291 Discontinued
0.7885 Intermediate Similarity NPD2674 Phase 3
0.7829 Intermediate Similarity NPD8251 Approved
0.7829 Intermediate Similarity NPD8252 Approved
0.7829 Intermediate Similarity NPD8099 Discontinued
0.7821 Intermediate Similarity NPD3144 Approved
0.7821 Intermediate Similarity NPD3145 Approved
0.7811 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7809 Intermediate Similarity NPD7132 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD8156 Discontinued
0.7784 Intermediate Similarity NPD4017 Approved
0.7778 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7831 Phase 2
0.7778 Intermediate Similarity NPD7833 Phase 2
0.7758 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD6107 Approved
0.7714 Intermediate Similarity NPD2898 Approved
0.7683 Intermediate Similarity NPD5241 Discontinued
0.7665 Intermediate Similarity NPD2122 Discontinued
0.7614 Intermediate Similarity NPD2489 Approved
0.7614 Intermediate Similarity NPD27 Approved
0.7595 Intermediate Similarity NPD5718 Phase 2
0.7594 Intermediate Similarity NPD7034 Discontinued
0.759 Intermediate Similarity NPD3124 Discontinued
0.759 Intermediate Similarity NPD2420 Approved
0.759 Intermediate Similarity NPD2421 Approved
0.7569 Intermediate Similarity NPD5917 Clinical (unspecified phase)
0.756 Intermediate Similarity NPD6030 Approved
0.756 Intermediate Similarity NPD6031 Approved
0.7545 Intermediate Similarity NPD4123 Phase 3
0.7531 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD3845 Phase 1
0.7515 Intermediate Similarity NPD6331 Phase 2
0.75 Intermediate Similarity NPD4166 Phase 2
0.7486 Intermediate Similarity NPD5313 Approved
0.7486 Intermediate Similarity NPD5312 Approved
0.7473 Intermediate Similarity NPD7310 Approved
0.7473 Intermediate Similarity NPD7312 Approved
0.7473 Intermediate Similarity NPD7313 Approved
0.7473 Intermediate Similarity NPD7311 Approved
0.7471 Intermediate Similarity NPD5604 Discontinued
0.747 Intermediate Similarity NPD3692 Discontinued
0.7469 Intermediate Similarity NPD6896 Approved
0.7469 Intermediate Similarity NPD6895 Approved
0.7458 Intermediate Similarity NPD2970 Approved
0.7458 Intermediate Similarity NPD2969 Approved
0.7458 Intermediate Similarity NPD4083 Discontinued
0.7443 Intermediate Similarity NPD7802 Discontinued
0.7442 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7432 Intermediate Similarity NPD7309 Approved
0.7421 Intermediate Similarity NPD2669 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD6297 Approved
0.7401 Intermediate Similarity NPD3051 Approved
0.7401 Intermediate Similarity NPD6071 Discontinued
0.7399 Intermediate Similarity NPD5773 Approved
0.7399 Intermediate Similarity NPD5772 Approved
0.7378 Intermediate Similarity NPD1632 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD5109 Approved
0.7375 Intermediate Similarity NPD5111 Phase 2
0.7375 Intermediate Similarity NPD5110 Phase 2
0.7348 Intermediate Similarity NPD3920 Phase 2
0.7337 Intermediate Similarity NPD6853 Approved
0.7337 Intermediate Similarity NPD6851 Approved
0.7326 Intermediate Similarity NPD4675 Approved
0.7326 Intermediate Similarity NPD4678 Approved
0.7322 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD6788 Approved
0.7312 Intermediate Similarity NPD7906 Approved
0.7308 Intermediate Similarity NPD6996 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD6612 Phase 2
0.7289 Intermediate Similarity NPD7153 Discontinued
0.7287 Intermediate Similarity NPD3924 Approved
0.7287 Intermediate Similarity NPD3923 Approved
0.7287 Intermediate Similarity NPD3921 Approved
0.7287 Intermediate Similarity NPD3922 Approved
0.7283 Intermediate Similarity NPD3534 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD4055 Discovery
0.7267 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD5177 Phase 3
0.7193 Intermediate Similarity NPD52 Approved
0.7193 Intermediate Similarity NPD7526 Approved
0.7193 Intermediate Similarity NPD7527 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD4578 Approved
0.7189 Intermediate Similarity NPD4577 Approved
0.7184 Intermediate Similarity NPD7109 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD7110 Phase 1
0.7181 Intermediate Similarity NPD6377 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD7598 Phase 2
0.7173 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD2161 Phase 2
0.7166 Intermediate Similarity NPD4663 Approved
0.7159 Intermediate Similarity NPD2560 Approved
0.7159 Intermediate Similarity NPD2563 Approved
0.7151 Intermediate Similarity NPD6618 Phase 2
0.7143 Intermediate Similarity NPD7493 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5525 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD3060 Approved
0.7126 Intermediate Similarity NPD3656 Approved
0.7118 Intermediate Similarity NPD7124 Phase 2
0.7102 Intermediate Similarity NPD2978 Approved
0.7102 Intermediate Similarity NPD2977 Approved
0.7097 Intermediate Similarity NPD7281 Phase 3
0.7097 Intermediate Similarity NPD7280 Phase 3
0.7093 Intermediate Similarity NPD6090 Discontinued
0.7088 Intermediate Similarity NPD5966 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD7438 Suspended
0.7083 Intermediate Similarity NPD7045 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD3109 Approved
0.7073 Intermediate Similarity NPD3110 Approved
0.7072 Intermediate Similarity NPD6687 Approved
0.7072 Intermediate Similarity NPD6688 Approved
0.7069 Intermediate Similarity NPD6523 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD5978 Approved
0.7062 Intermediate Similarity NPD8095 Phase 1
0.7062 Intermediate Similarity NPD3837 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD5977 Approved
0.7059 Intermediate Similarity NPD5084 Clinical (unspecified phase)
0.7053 Intermediate Similarity NPD2488 Approved
0.7053 Intermediate Similarity NPD2490 Approved
0.7053 Intermediate Similarity NPD6656 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD1669 Approved
0.7041 Intermediate Similarity NPD44 Approved
0.7041 Intermediate Similarity NPD6364 Approved
0.7033 Intermediate Similarity NPD4481 Phase 3
0.7029 Intermediate Similarity NPD6876 Approved
0.7029 Intermediate Similarity NPD6875 Approved
0.7018 Intermediate Similarity NPD6783 Clinical (unspecified phase)
0.7011 Intermediate Similarity NPD5267 Discontinued
0.7011 Intermediate Similarity NPD2883 Discontinued
0.7006 Intermediate Similarity NPD1753 Discontinued
0.7 Intermediate Similarity NPD3408 Clinical (unspecified phase)
0.6994 Remote Similarity NPD5261 Clinical (unspecified phase)
0.698 Remote Similarity NPD3815 Phase 1
0.698 Remote Similarity NPD3816 Phase 1
0.6979 Remote Similarity NPD6046 Clinical (unspecified phase)
0.6973 Remote Similarity NPD7479 Phase 2
0.6966 Remote Similarity NPD6063 Approved
0.6961 Remote Similarity NPD8149 Discontinued
0.6959 Remote Similarity NPD5307 Clinical (unspecified phase)
0.6957 Remote Similarity NPD3053 Approved
0.6957 Remote Similarity NPD3055 Approved
0.6954 Remote Similarity NPD6662 Clinical (unspecified phase)
0.6951 Remote Similarity NPD2028 Clinical (unspecified phase)
0.6949 Remote Similarity NPD5720 Discontinued
0.6947 Remote Similarity NPD7243 Clinical (unspecified phase)
0.6941 Remote Similarity NPD2460 Phase 3
0.6941 Remote Similarity NPD2458 Approved
0.6941 Remote Similarity NPD2459 Approved
0.6941 Remote Similarity NPD4162 Approved
0.694 Remote Similarity NPD6607 Clinical (unspecified phase)
0.6937 Remote Similarity NPD3676 Clinical (unspecified phase)
0.6936 Remote Similarity NPD2874 Phase 2
0.6927 Remote Similarity NPD4581 Clinical (unspecified phase)
0.691 Remote Similarity NPD6060 Clinical (unspecified phase)
0.6909 Remote Similarity NPD7477 Discontinued
0.6905 Remote Similarity NPD4108 Discontinued
0.6905 Remote Similarity NPD6380 Phase 1
0.6899 Remote Similarity NPD2668 Approved
0.6899 Remote Similarity NPD2667 Approved
0.6897 Remote Similarity NPD7827 Phase 1
0.6894 Remote Similarity NPD5311 Approved
0.6894 Remote Similarity NPD7258 Clinical (unspecified phase)
0.6894 Remote Similarity NPD5310 Approved
0.6894 Remote Similarity NPD2922 Phase 1
0.6893 Remote Similarity NPD6072 Discontinued
0.689 Remote Similarity NPD5155 Approved
0.689 Remote Similarity NPD5156 Approved
0.6889 Remote Similarity NPD8070 Approved
0.6878 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6875 Remote Similarity NPD2232 Approved
0.6875 Remote Similarity NPD2230 Approved
0.6875 Remote Similarity NPD5641 Discontinued
0.6875 Remote Similarity NPD824 Approved
0.6875 Remote Similarity NPD2233 Approved
0.6875 Remote Similarity NPD2337 Clinical (unspecified phase)
0.6871 Remote Similarity NPD3636 Approved
0.6871 Remote Similarity NPD3635 Approved
0.6871 Remote Similarity NPD3637 Approved
0.6867 Remote Similarity NPD6346 Approved
0.686 Remote Similarity NPD8318 Clinical (unspecified phase)
0.6859 Remote Similarity NPD3349 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data